BRCA2
oracknows | May 20, 2013Just when I thought I was out, they pull me back in.
OK, I know I use that line entirely too much, but I also don't really care. When something fits, wear it. And if it doesn't fit, you must acquit. Sorry, I'll stop. I'm in a weird mood as I write this. But it's really hard not to get into a weird mood after reading the lastest bit by that crank to rule all cranks, that quack who tries to rule all quacks, Mike Adams, founder of NaturalNews.com. Last week, he laid down the vile stupid fast and furious to attack Angelina Jolie's decision to undergo bilateral prophylactic mastectomy. It was hard…
oracknows | May 15, 2013After yesterday, I really hadn't planned on writing about Angelina Jolie and her decision to undergo bilateral mastectomies again, except perhaps as a more serious piece next week on my not-so-super-secret other blog where The Name of the Doctor is revealed on a weekly basis. As I mentioned yesterday, there are a number of issues about the decision that could use my professional attention, from the process, to the evidence, to the issue of how the surgery was handled. Oh, and if I do decide to do that I'm sure I won't be able to resist a mention of some of the quackery that oozed out from…
rskloot | November 2, 2009
Some interesting news about the breast cancer patent lawsuit I wrote about for Slate's Double X Magazine a few months ago: A federal district court has just agreed to hear the case. When the lawsuit was first filed, many legal experts I talked to said they were sure the case would get thrown out of court for it's unusual approach, namely that it claims that the practice of patenting genes is unconstitutional See my story about the case here. Filings and other documents related to the case available here. And see below for the full press release about today's news:
Court Upholds Right of…
rskloot | May 15, 2009
Earlier this week, the American Civil Liberties Union and several other groups filed suit against Myriad Genetics -- the company that holds the patent on the breast cancer gene. They're hoping to get the breast cancer gene patent revoked, but more than that, they're aiming to stop gene patenting all together.
Today, in my new column in Slate's Double X Magazine, I go into the story of the breast cancer gene and the impact the ACLU claims it's had on science and patient care (a hint: it's not good). I also look at the suit itself, the cases that have come before this one, and what they say…